Abiogen Pharma Technographics
Abiogen Pharma Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Abiogen Pharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 160 Abiogen Pharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Abiogen Pharma has purchased the following applications: IQVIA OCE Sales for Sales Automation in 2018, Red Hat JBoss Enterprise Application Platform for Apps Development in 2014, OpenSSL for Secure Sockets Layer (SSL) in 2023 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Abiogen Pharma is running and its propensity to invest more and deepen its relationship with IQVIA , Red Hat , OpenSSL or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Abiogen Pharma revenues, which have grown to $40.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Abiogen Pharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Abiogen Pharma Tech Stack and Enterprise Applications
Abiogen Pharma CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| IQVIA | Legacy | IQVIA OCE Sales | Sales Automation | CRM | n/a | 2018 | 2020 |
In 2018, Abiogen Pharma deployed IQVIA OCE Sales to provision Sales Automation capabilities for its Italian commercial organization and field force. The deployment centered on enabling virtual HCP interactions using IQVIA OCE Sales and the Remote Engagement module to support remote detailing and activity capture for sales and medical teams in Italy.
The implementation configured remote engagement workflows, call planning and CRM activity logging to match existing sales and CRM processes, with the remote solution brought online in about one week. Architecturally the rollout emphasized the Remote Engagement module as the operational layer for virtual calls, supporting rapid transition to remote engagement and high frequency call activity by field users.
Operational scope was focused on sales and CRM processes across Italy, with the remote detailing capability used daily by field teams to maintain business continuity during COVID-19. The program achieved rapid adoption, generating hundreds of remote calls per day and delivering improved field productivity as reported by the customer.
|
Abiogen Pharma PaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Red Hat | Legacy | Red Hat JBoss Enterprise Application Platform | Apps Development | PaaS | n/a | 2014 | 2014 |
|
Abiogen Pharma CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| OpenSSL | Legacy | OpenSSL | Secure Sockets Layer (SSL) | CyberSecurity | n/a | 2023 | 2023 |
|
IT Decision Makers and Key Stakeholders at Abiogen Pharma
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Abiogen Pharma Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||